Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Scientific Officer

Chief Medical Officer

Chief Executive Officer

Chief Fin. and Bus. Officer

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy; TN-301, a small molecule for heart failure with preserved ejection fraction; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy. It also develops an adeno-associated virus-based gene therapy designed to deliver the dwarf open reading frame gene in the heart for dilated cardiomyopathy; and reprogramming program for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-23	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-23	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-02-23	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-02-23	Premium	acquired	Premium	Premium	Premium	Chief Fin. and Bus. Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Fin. and Bus. Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-12	Premium	bought	Premium	Premium	Premium	-
2024-02-12	Premium	bought	Premium	Premium	Premium	-
2023-08-29	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-08-16	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-08-16	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-08-16	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-08-16	Premium	sold	Premium	Premium	Premium	Chief Fin. and Bus. Officer
2023-03-10	Premium	bought	Premium	Premium	Premium	-
2023-03-10	Premium	bought	Premium	Premium	Premium	-
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Fin. and Bus. Officer
2023-02-08	Premium	bought	Premium	Premium	Premium	-
2023-02-08	Premium	bought	Premium	Premium	Premium	-

TNYA - Tenaya Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for TNYA